MIAOZHEN QIU

MIAOZHEN QIU

Sun Yat-Sen University

H-index: 43

Asia-China

About MIAOZHEN QIU

MIAOZHEN QIU, With an exceptional h-index of 43 and a recent h-index of 31 (since 2020), a distinguished researcher at Sun Yat-Sen University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

The relationship between brain metastasis and HER2 expression status in gastric cancer

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation

An open-label, single-arm, dose escalation and expansion phase 1 study of tebotelimab (MGD013) plus niraparib in patients with locally advanced or metastatic gastric cancer who …

Combination Therapies for Treating Cancer

A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors.

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

MIAOZHEN QIU Information

University

Position

Cancer Center

Citations(all)

6081

Citations(since 2020)

3743

Cited By

3596

hIndex(all)

43

hIndex(since 2020)

31

i10Index(all)

119

i10Index(since 2020)

103

Email

University Profile Page

Sun Yat-Sen University

Google Scholar

View Google Scholar Profile

Top articles of MIAOZHEN QIU

Title

Journal

Author(s)

Publication Date

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Nature Medicine

Feng Wang

Ying Jin

Min Wang

Hui-Yan Luo

Wei-Jia Fang

...

2024/3/4

The relationship between brain metastasis and HER2 expression status in gastric cancer

Clinical and Translational Oncology

Ming-Yu Lai

Wen-Long Guan

Jing Yang

Yu-Ting Sun

Shi-Xun Lu

...

2024/3

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

Cancer Communications

Feng‐Hua Wang

Xiao‐Tian Zhang

Lei Tang

Qi Wu

Mu‐Yan Cai

...

2024/1

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation

Cellular & Molecular Immunology

Fan Luo

Han Li

Wenjuan Ma

Jiaxin Cao

Qun Chen

...

2024/1

An open-label, single-arm, dose escalation and expansion phase 1 study of tebotelimab (MGD013) plus niraparib in patients with locally advanced or metastatic gastric cancer who …

Miaozhen Qiu

Hongming Pan

Ka On Lam

Jufeng Wang

Yi Zheng

...

2023/2/1

Combination Therapies for Treating Cancer

2022/9/7

A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors.

Rui-hua Xu

Xiaoli Wei

Dongsheng Zhang

Miaozhen Qiu

Yang Zhang

...

2023/2/1

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

Signal Transduction and Targeted Therapy

Miao-Zhen Qiu

Chaoye Wang

Zhiying Wu

Qi Zhao

Zhibin Zhao

...

2023/9/21

Retraction Note: Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer

Cell Death & Disease

Hong-En Yu

Feng Wang

Fang Yu

Zhao-Lei Zeng

Yun Wang

...

2023/1

Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins

Cell Reports

Miao-Zhen Qiu

Qingjian Chen

Dan-Yang Zheng

Qi Zhao

Qi-Nian Wu

...

2023/6/27

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials

The Oncologist

Xiao-Li Wei

Yang Zhang

Hong-Yun Zhao

Wen-Feng Fang

Hui-Yan Luo

...

2023/1/1

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1

Genes

Ye Hong

Zengfei Xia

Yuting Sun

Yingxia Lan

Tian Di

...

2023/4/10

Caspase-3 mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer

Cancer Research

Qiuyun Luo

Zengfei Xia

Jing Yang

Wentao Pan

Fan Luo

...

2023/4/4

First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors

Nature Communications

Xiao-Li Wei

Fu-Rong Liu

Ji-Hong Liu

Hong-Yun Zhao

Yang Zhang

...

2022/11/16

Combination of FAK inhibitor and BTK inhibitor for treating a disease

2022/4/21

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment

Gut

Feng Wang

You-Sheng Huang

Hao-Xiang Wu

Zi-Xian Wang

Ying Jin

...

2022/7/1

Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma

Cell Reports Medicine

Yang Zhang

Miao-Zhen Qiu

Ju-Feng Wang

Yan-Qiao Zhang

Ao Shen

...

2022/11/15

Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature

Jian-Ying Xu

Wen-Long Guan

Shi-Xun Lu

Xiao-Li Wei

Wen-Jie Shi

...

2022/4

Predictive biomarkers for the efficacy of PD-1 inhibitors plus chemotherapy for gastric/gastroesophageal junction cancer in first-line setting

Cancer Research

Yu-Ting Sun

Shi-Xun Lu

Ming-Yu Lai

Xia Yang

Wen-Long Guan

...

2022/6/15

Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer

BMC cancer

Ming-Yu Lai

Shi-Yang Kang

Yu-Ting Sun

Ting-Ting Quan

Shi-Xun Lu

...

2022/10/1

See List of Professors in MIAOZHEN QIU University(Sun Yat-Sen University)